Volume 26, Issue 6P2 p. 55S-60S

Treatment Options for Invasive Fungal Infections

Elizabeth S. Dodds Ashley Pharm.D.

Corresponding Author

Elizabeth S. Dodds Ashley Pharm.D.

Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina; and Campbell University School of Pharmacy, Buies Creek, North Carolina.

Elizabeth S. Dodds Ashley, Pharm.D., Duke University Medical Center, DUMC-3281, Durham, NC 27710.Search for more papers by this author
First published: 06 January 2012
Citations: 6

Abstract

Clinicians face an increasing occurrence of invasive fungal infections. These are due not only to traditional yeast and mould species but also to rare pathogens that can be difficult to treat. The introduction of new agents has expanded the options for treating common and rare mycotic infections with antifungal efficacy at least equal, and safety far superior, to that of a once-limited choice of therapies. Patients with invasive mycoses frequently have concomitant disorders and require multidrug regimens. Clinicians must be aware of the potential for interactions among agents available for treating invasive mycoses in patients with serious underlying conditions.